This course has expired. View available courses.
Cardiology
Oral Anticoagulation; Improving AF and VTE outcomes (2021 Update)
Direct oral anticoagulants (DOACs) are increasingly encountered in pharmacy practice, for use in patients with atrial fibrillation (AF), deep vein thrombosis (DVT), and peripheral artery disease (PAD). As a result, pharmacists are often asked challenging questions regarding the practical management of patients on DOAC therapy. This lesson provides a practical overview to answering these questions, with a focus on:
- The role of DOAC therapy in patients with atrial fibrillation (AF) and deep vein thrombosis (DVT)
- Optimizing DOAC therapy according to key patient characteristics
- The pharmacist’s role in assessing, managing, and monitoring patients on DOAC therapy
This program has received an unrestricted educational grant or in-kind support from BMS-Pfizer Alliance
DURATION
2 hr
PROFESSION
Pharmacy
# OF CREDITS
2
ACCREDITATION
CCCEP
EXPIRY DATE
2022-02-15
Direct oral anticoagulants (DOACs) are increasingly encountered in pharmacy practice, for use in patients with atrial fibrillation (AF), deep vein thrombosis (DVT), and peripheral artery disease (PAD). As a result, pharmacists are often asked challenging questions regarding the practical management of patients on DOAC therapy. This lesson provides a practical overview to answering these questions, with a focus on:
- The role of DOAC therapy in patients with atrial fibrillation (AF) and deep vein thrombosis (DVT)
- Optimizing DOAC therapy according to key patient characteristics
- The pharmacist’s role in assessing, managing, and monitoring patients on DOAC therapy
This program has received an unrestricted educational grant or in-kind support from BMS-Pfizer Alliance
Faculty
Francis Richard, PharmD, MScPhm, BCMTMS
John Papastergiou, BSc, BSc(Pharm)
Reginald Smith, BSc(Pharm), Pharm.D.
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Recommend safe, effective, and appropriate use of direct oral anticoagulant (DOAC) therapy in patients with atrial fibrillation (AF), deep vein thrombosis (DVT), and peripheral artery disease.
- Optimize DOAC therapy and dosage for the management of AF or DVT, based on patient characteristics such as renal function, concomitant medications, bleeding risk, age, and weight.
- Describe strategies for managing anticoagulation in patients undergoing a minor or major surgical procedure.
- Counsel patients on the safe and appropriate use of DOAC medications to support best outcomes
Accreditation
CCCEP File Number: 1066-2019-2892-I-P
#
of credits: 2
Duration: 2 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
2 hr
Duration
Pharmacy
Profession
2
# of credits
Learning Objectives
Upon completion of this continuing education program, participants will be better able to:
- Recommend safe, effective, and appropriate use of direct oral anticoagulant (DOAC) therapy in patients with atrial fibrillation (AF), deep vein thrombosis (DVT), and peripheral artery disease.
- Optimize DOAC therapy and dosage for the management of AF or DVT, based on patient characteristics such as renal function, concomitant medications, bleeding risk, age, and weight.
- Describe strategies for managing anticoagulation in patients undergoing a minor or major surgical procedure.
- Counsel patients on the safe and appropriate use of DOAC medications to support best outcomes
CCCEP
Accredited
Course
CCCEP
ACCREDITATION
Cardiology
Learning Category
General
Topic
0
Price
2022-02-15
Expiry Date
CAN-eng
Region/Language
Course Description
Direct oral anticoagulants (DOACs) are increasingly encountered in pharmacy practice, for use in patients with atrial fibrillation (AF), deep vein thrombosis (DVT), and peripheral artery disease (PAD). As a result, pharmacists are often asked challenging questions regarding the practical management of patients on DOAC therapy. This lesson provides a practical overview to answering these questions, with a focus on:
- The role of DOAC therapy in patients with atrial fibrillation (AF) and deep vein thrombosis (DVT)
- Optimizing DOAC therapy according to key patient characteristics
- The pharmacist’s role in assessing, managing, and monitoring patients on DOAC therapy
This program has received an unrestricted educational grant or in-kind support from BMS-Pfizer Alliance
Faculty
Francis Richard, PharmD, MScPhm, BCMTMS
John Papastergiou, BSc, BSc(Pharm)
Reginald Smith, BSc(Pharm), Pharm.D.
Accreditation
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 2.0 CEU.
CCCEP File Number: 1066-2019-2892-I-P
2 hr
Duration
0
Price
2
# of credits
